Initial Beneficial Ownership · 3
Prenetics Global Limited
PRENASDAQEQUITYCurrent
Initial Beneficial Ownership
Structured filing — 3
wk-form3_1787746258.xml
Filing details
- Report period
- 2026-08-17
- Issuer
- Prenetics Global Ltd
- Issuer CIK
- 0001876431
- Trading symbol
- PRE
Reporting owner 1
- Name
- Levy Caroline S
- Reporting owner CIK
- 0001820042
- Relationship
- Director
- Address
- UNIT 703-706, K11 ATELIER, 728 KINGS ROAD, QUARRY BAY, HONG KONG, HONG KONG, K3
Derivative holdings
| Security | Conversion / exercise price | Exercisable | Expires | Underlying security | Underlying shares | Ownership |
|---|---|---|---|---|---|---|
| Restricted Stock Unit | 0 | [F1] | 2033-08-17 | Class A Ordinary Share, par value $0.0015 per share | 7,595 | D |
Table key
- D
- Direct
Footnotes
- F1
- Each Restricted Stock Unit ("RSU"), granted under the Issuer's 2022 Share Incentive Plan, represents a contingent right to receive one Class A Ordinary Share. 7,595 RSUs vest on August 17, 2027, subject to continued service. Upon vesting, the RSUs are settled and delivered in shares.↩ 1
Remarks
Exhibit 24 - Power of Attorney
Signature 1
- Signed
- s/ Stephen Hoi Chun Lo, as attorney-in-fact for Caroline Shan Levy
- Date
- 2026-08-26
Filed exhibits
- EX-24 ↗section16poalevy.htm
Company context
Prenetics (NASDAQ: PRE) is a leading health sciences company dedicated to advancing human health and longevity. The Company’s flagship consumer brand, IM8, co-founded with David Beckham and championed by World No. 1 tennis player Aryna Sabalenka, is redefining the premium daily nutrition category through science-backed formulations and global brand partnerships. Since its launch, IM8 has become one of the fastest-growing brands in consumer health, achieving an impressive milestone of surpassing $100 million in annualized recurring revenue within just 11 months of operations, and is now sold in more than 40 countries worldwide.